This inventor holds 3 USPTO granted patents. Top assignees: Imperial Chemical Industries Limited, Ici Pharma. Active years: 1985-1987.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 1985-1987
Title: Frank Loftus: Innovator in Pharmaceutical Chemistry
Introduction
Frank Loftus is a notable inventor based in Macclesfield, GB. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of cephalosporin derivatives. With a total of 3 patents to his name, Loftus has demonstrated a commitment to advancing medical science through innovative solutions.
Latest Patents
Loftus's latest patents include a process for the manufacture of substituted cyanamide compounds useful for the production of cephalosporin derivatives. The first patent outlines a method characterized by the reaction of specific compounds to create a cephalosporin derivative, where various radicals and protecting groups are utilized. The second patent details a process for preparing cephalosporin derivatives, emphasizing the cyclization of compounds and the replacement of protecting groups to yield the desired pharmaceutical products.
Career Highlights
Throughout his career, Frank Loftus has worked with prominent companies such as Imperial Chemical Industries Limited and ICI Pharma. His experience in these organizations has allowed him to refine his expertise in pharmaceutical development and innovation.
Collaborations
Loftus has collaborated with notable professionals in the field, including Frederic H Jung and Annie A Olivier. These partnerships have contributed to his success and the advancement of his research.
Conclusion
Frank Loftus is a distinguished inventor whose work in pharmaceutical chemistry has led to valuable innovations in cephalosporin derivatives. His contributions continue to impact the field positively, showcasing the importance of innovation in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile